Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity-Reply
- PMID: 34436516
- DOI: 10.1001/jamaoncol.2021.3344
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity-Reply
Comment on
-
Evolution of the Randomized Clinical Trial in the Era of Precision Oncology.JAMA Oncol. 2021 May 1;7(5):728-734. doi: 10.1001/jamaoncol.2021.0379. JAMA Oncol. 2021. PMID: 33764385 Free PMC article. Clinical Trial.
-
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.JAMA Oncol. 2021 Oct 1;7(10):1578-1579. doi: 10.1001/jamaoncol.2021.3341. JAMA Oncol. 2021. PMID: 34436547 No abstract available.
-
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.JAMA Oncol. 2021 Oct 1;7(10):1577-1578. doi: 10.1001/jamaoncol.2021.3338. JAMA Oncol. 2021. PMID: 34436567 No abstract available.
-
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.JAMA Oncol. 2021 Oct 1;7(10):1577. doi: 10.1001/jamaoncol.2021.3335. JAMA Oncol. 2021. PMID: 34436578 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
